Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

EGFR targeted therapy in lung cancer; an evolving story.

Bartholomew C, Eastlake L, Dunn P, Yiannakis D.

Respir Med Case Rep. 2017 Feb 4;20:137-140. doi: 10.1016/j.rmcr.2017.01.016. eCollection 2017.

2.

Linking genotoxicity and cytotoxicity with membrane fluidity: A comparative study in ovarian cancer cell lines following exposure to auranofin.

Oommen D, Dodd NJ, Yiannakis D, Moyeed R, Jha AN.

Mutat Res. 2016 Oct;809:43-49. doi: 10.1016/j.mrgentox.2016.09.003. Epub 2016 Sep 4.

PMID:
27692298
3.

BRCA1 deficiency increases the sensitivity of ovarian cancer cells to auranofin.

Oommen D, Yiannakis D, Jha AN.

Mutat Res. 2016 Feb-Mar;784-785:8-15. doi: 10.1016/j.mrfmmm.2015.11.002. Epub 2015 Nov 28.

PMID:
26731315
4.

Unilateral Optic Disc Papilloedema following Administration of Carboplatin Chemotherapy for Ovarian Carcinoma.

Lewis P, Waqar S, Yiannakis D, Raman V.

Case Rep Oncol. 2014 Jan 10;7(1):29-32. doi: 10.1159/000357912. eCollection 2014 Jan.

5.

Occupational exposure to anti-cancer drugs: A review of effects of new technology.

Vyas N, Yiannakis D, Turner A, Sewell GJ.

J Oncol Pharm Pract. 2014 Aug;20(4):278-87. doi: 10.1177/1078155213498630. Epub 2013 Aug 22. Review.

PMID:
23975555
6.

Resistance gene expression determines the in vitro chemosensitivity of non-small cell lung cancer (NSCLC).

Glaysher S, Yiannakis D, Gabriel FG, Johnson P, Polak ME, Knight LA, Goldthorpe Z, Peregrin K, Gyi M, Modi P, Rahamim J, Smith ME, Amer K, Addis B, Poole M, Narayanan A, Gulliford TJ, Andreotti PE, Cree IA.

BMC Cancer. 2009 Aug 27;9:300. doi: 10.1186/1471-2407-9-300.

7.

Alveolar soft part sarcoma of the uterine cervix.

Gitau GM, Shepherd JH, Hughes G, Oriolowo A, Yiannakis D.

Int J Gynecol Cancer. 2008 Jul-Aug;18(4):853-6. Epub 2007 Oct 24.

PMID:
17961160
8.

Marked response to a cisplatin/docetaxel/temozolomide combination in a heavily pretreated patient with metastatic large cell neuroendocrine lung carcinoma.

Gounaris I, Rahamim J, Shivasankar S, Earl S, Lyons B, Yiannakis D.

Anticancer Drugs. 2007 Nov;18(10):1227-30.

PMID:
17893525
9.

Nongestational choriocarcinoma arising from a primary ovarian tumour.

Oladipo A, Mathew J, Oriolowo A, Lindsay I, Fisher R, Seckl M, Yiannakis D.

BJOG. 2007 Oct;114(10):1298-300. No abstract available.

10.

Endometrial carcinoma occurring beyond the radiotherapy field after treatment for Wilm's tumour.

Scott E, Yiannakis DH.

Clin Oncol (R Coll Radiol). 2004 Feb;16(1):80-1. No abstract available.

PMID:
14768762
11.

The role of ultrasonographically guided puncture of the human rete testis in the therapeutic management of nonobstructive azoospermia.

Kaponis A, Yiannakis D, Tsoukanelis K, Tsalikis D, Tsabalas D, Baltogiannis D, Giannakopoulos X, Schrader M, Georgiou I, Yamamoto Y, Kanakas N, Miyagawa I, Loutradis D, Touloupidis S, Sofikitis N.

Andrologia. 2003 Apr;35(2):85-92.

PMID:
12653781

Supplemental Content

Loading ...
Support Center